key: cord-0774914-ne0qwv56 authors: Han, Chuanliang; Liu, Yimeng; Yang, Saini title: Intrinsic growth rules of patients infected, dead and recovered with 2019 novel coronavirus in mainland China date: 2020-02-25 journal: nan DOI: 10.1101/2020.02.23.20024802 sha: 596e5de26c413e61bc4aea5bb8d1a72821db11d8 doc_id: 774914 cord_uid: ne0qwv56 An outbreak of a novel coronavirus (SARS-CoV-2)-infected pneumonia (COVID-19) was first diagnosed in Wuhan, China, in December 2019 and then spread rapidly to other regions. We collected the time series data of the cumulative number of confirmed infected, dead, and cured cases from the health commissions in 31 provinces in mainland China. A descriptive model in a logistic form was formulated to infer the intrinsic epidemic rules of COVID-19, which illustrates robustness spatially and temporally. Our model is robust (R2>0.95) to depict the intrinsic growth rule for the cumulative number of confirmed infected, dead, and cured cases in 31 provinces in mainland China. Furthermore, we compared the intrinsic epidemic rules of COVID-19 in Hubei with that of severe acute respiratory syndrome (SARS) in Beijing, which was obtained from the Ministry of Public Health of China in 2003. We found that the infected case is the earliest to be saturated and has the lowest semi-saturation period compared with deaths and cured cases for both COVID-19 and SARS. All the three types of SARS cases are later to saturate and have longer semi-saturation period than that of COVID-19. Despite the virus caused SARS (SARS-CoV) and the virus caused COVID-19 (SARS-CoV-2) are homologous, the duration of the outbreak would be shorter for COVID-19. different provinces. By comparing fitted parameters, we found that the fitted curve of 48 infected case is the earliest to be saturated and has the lowest semi-saturation period 49 in both COVID-19 and SARS. While all three population groups of SARS is later to 50 saturate and has longer semi-saturation period than that of Conclusions 52 Our model is robust and stable to depict the intrinsic growth rule for the cumulative 53 number of confirmed infected, dead, and cured cases in 30 provinces, which could 54 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint In December 2019, a novel coronavirus-infected pneumonia causing human infection 61 was first identified in Wuhan, a city of Hubei province located in central China with a 62 population of 11 million people (Zhu et al., 2020; Hui et al., 2020) . The coronavirus 63 was firstly named as 2019-nCoV on January 12, 2020 and may have a probable bat 64 origin (Zhou et al., 2020) . Human to human transmission through 2019-nCoV has 65 been confirmed among closed contacts since the middle of December 2019 (Wang et 66 al. 2020; Li et al., 2020) . As of February 12, 2020, infections of 2019-nCoV have been 67 identified in all Chinese provincial administrative regions and in dozens of countries 68 around the world (Munster et al., 2020; Holshue et al, 2020; Ki et al., 2020; 69 Shigemura et al., 2020; Nshiera et al., 2020) . So far, the coronavirus has been 70 renamed as COVID-19 on February 12, 2020 officially. Different from a previous 71 famous beta coronavirus in 2003, severe acute respiratory syndrome coronavirus 72 (SARS-CoV) (Ksiazek et al., 2003; Kuiken et al., 2003; Drosten et al., 2003) is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 25, 2020 . . https://doi.org/10.1101 /2020 We obtained the time series data of 2019-nCoV cases from the National Health 87 Commission of China, and the provincial Health Commission of 31 provincial 88 administrative regions in Mainland China (January 20 to February 19, 2020). The data 89 used in this study include the number of confirmed 2019-nCoV cases, the cumulative 90 number of suspected, dead, and cured cases. All cases were laboratory confirmed 91 following the case definition by national health commission of China (from CCDC 92 website). The basic test procedure has been described in detail in previous work 93 (Huang et al., 2020; Li et al., 2020) . We only chose the cases that are tested positive 94 by real-time RT-PCR with specific primers and probes to SARS-CoV-2 both at the 95 corresponding provincial CDC and the National Institute for Viral Disease Control at 96 The severe acute respiratory syndrome (SARS) in 2003 was another fatal coronavirus 99 epidemics over the last two decades, we collected the data (the cumulative number of 100 suspected, dead, and cured cases) of SARS during March 1 to August 16, 2003, in 101 Beijing from the National Health and Family Planning Commission of PRC. 102 103 We assumed that the population of each region was susceptible to COVID-19, the 105 number of susceptible people per unit time was proportional to the number of 106 uninfected persons, and isolation or closure of the city could affect the spread effect of 107 infected to susceptible people to a certain extent. Previous studies have showed that 108 daily cumulative number of patients could be explained by logistic function (Huang et 109 al., 2003; Wang et al., 2003) . Based on the above assumption and previous studies, we 110 modeled the epidemic information of virus as logistic form (Eq. (1)) 111 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 25, 2020. . https://doi.org/10.1101/2020.02.23.20024802 doi: medRxiv preprint where N 1 is maximum number of cumulative infections, I(t) is cumulative number of 113 patients at time t, is the incidence growth rate, and I 0 is the number of infected 114 cases at the initial time. 115 Analytical solution of Eq. (1) could be written in the form of Eq. (2) 116 Similarly, we could write the analytical solutions for the dead and cured cases by Eq. 119 (4) and Eq. (6). 120 Where , is the growth rate of dead cases and the growth rate of cured cases, 125 respectively. N 2 and N 3 is maximum number of cumulative dead and cured cases. D 0 126 and R 0 is the number of dead and cured cases at initial time. 127 Here we simplified Eqs. (2),(4),(6) and unified them as Eq. (8) 128 where N(t) is the general form of I(t), D(t) or R(t), A denotes N 1 , N 2 , or N 3 , and k 130 represents , , or , indicating the intrinsic rule for growth of cases. t 0 represents 131 the semi-saturation period, illustrating the inflection point of the sigmoid curve. 132 The data processing and modeling were performed on MATLAB (The MathWorks) 134 with custom scripts. The nonlinear least square (NLS) algorithm was adopted for data 135 fitting and parameter estimation. We used the MATLAB function "nlinfit" to 136 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 25, 2020. . https://doi.org/10.1101/2020.02.23.20024802 doi: medRxiv preprint minimize the sum of squared differences between the data points and the fitted values. 137 Eq. (8) was used in this work as the descriptive model to depict the intrinsic growth 138 rule for infected, dead and cured cases. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 25, 2020. In our model, k is an important parameter to depict the intrinsic growth rule of 158 cumulative number of infected patients (Eq. (8)). Based on our assumption, the 159 growth pattern was supposed to follow a sigmoid form, and the parameter k here 160 denotes how rapid the number of infected cases get to saturate. If k is large, the S form 161 of the curve would be sharp, and the curve will rise up very quickly to be saturated to 162 the maximum number. While if k is only slightly larger than 0, the curve would show 163 a slow and smooth increase from 0 to the maximum. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 25, 2020. . https://doi.org/10. 1101 /2020 increase since Jan 29, 2020. And the only one confirmed case in Tibet has been cured 169 on Feb 12. The spatial distribution of parameter k is shown in Fig 2A, We found the k value of fitted curves of infected SARS cases in Beijing was 0.18, 193 which was much lower than that of Hubei province of COVID-19 (k = 0.25) (Fig 3 194 ABC). Furthermore, we found that all 30 provinces' k value were significantly larger 195 than 0.18 (Fig 3D) . We also noted the t 0 of fitted curves of infected SARS cases in 196 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 25, 2020. . https://doi.org/10. 1101 /2020 province in mainland China (Fig 3E) . Moreover, the increasing rate (k) was negatively 198 correlated (Pearson, p=0 .0072) to semi-saturation period (Fig 3F) . We 199 concluded that at the provincial level, the COVID-19 spread more quickly than the 200 SARS did. The infections of COVID-19 increased more rapid and would reach 201 saturation earlier than SARS according to our model. by two parameters, k and t 0 (Fig 4 DEIJ) . We found that k values of the three types 211 cases of SARS were lower than that of COVID-19 (Fig 4 DE) , and semi-saturation 212 period for them in SARS was higher than COVID-19's, which suggested the duration 213 of COVID-19 would be shorter than that of SARS. For both SARS and COVID-19, 214 their infected curves have the lowest semi-saturation period (Fig 4 EJ) , while cured 215 curves have the highest which is in keeping with the common sense that the cure is 216 Hubei, the k values of death case curves were lowest compared with curves of 218 infected cases and cured cases. For both SARS and COVID-19, the k value of infected 219 case curve was larger than that of cured curve. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 25, 2020. or SEIR (Susceptible -Exposed -Infectious -Recovered), our model is relatively 231 simple but robust. We used a differential equation in logistic form to describe the 232 dynamics of the infected, dead and healed cases caused by COVID-19 respectively 233 (See Methods). The increasing of the population no matter in which type of case 234 (infection, death or recovery) has multiple reasons. When the outbreak of COVID-19 235 originated in Wuhan, it did not cause too much concern at the beginning so that it 236 leads to many infections and starts to export potential exposed cases to other 237 provinces. But as the successive closure of the cities in Hubei province, and isolation 238 of the community in all the provinces in mainland China, the virus spread tendency 239 was weakened. In our model, we also considered these measures taken by the 240 government. We rewrote Eq. (1) to Eq. (9). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 25, 2020 . . https://doi.org/10.1101 /2020 cured cases will rise up quickly. The growth of cured cases would again be slow since 252 the number of patients is limited. All these facts were considered in our highly 253 summarized model (Eq. (8) ) in a macroscopic scale. All data sets have a R-square 254 greater than 0.95 when fitted by our framework, so that we could further discuss some this guides us to be more careful against the epidemic. Further we compared this 263 characteristics between COVID-19 and SARS in 2003 in typical provinces (Fig 3 AB) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 25, 2020 . . https://doi.org/10.1101 /2020 curves of infections have lowest semi-saturation period (Fig 4 EK) , while fitted 280 curves of cured cases have the highest semi-saturation period, which follows the 281 common sense that the cure was always later than infection and death since it costs 282 time to get on the research of effect plans to cure the patients. For both SARS and 283 COVID-19, the k value of infected case curve was larger than that of cured curve, 284 while that of death case is the lowest. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 25, 2020 . . https://doi.org/10.1101 /2020 Holshue ML et al. (2020) is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 25, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 25, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 25, 2020. . https://doi.org/10. 1101 /2020 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 25, 2020. . https://doi.org/10. 1101 /2020 Identification of a novel coronavirus in 288 patients with severe acute respiratory syndrome is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 25, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 25, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted February 25, 2020. . https://doi.org/10. 1101 /2020